Google DeepMind launches AI co-clinician research program with multimodal AI agent

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
AI + crypto news: On April 30, 2026, Google DeepMind launched its AI Co-Clinician research program, focusing on multimodal AI agents to assist medical professionals. The system enables real-time patient interactions, including history collection, physical examinations, and care recommendations. It employs a dual-agent architecture and the NOHARM safety framework. In testing, it achieved zero critical errors in 97 out of 98 cases and matched or outperformed humans in 68 out of 140 metrics. The project collaborates with Harvard and Stanford and remains in the research phase. On-chain news continues to highlight AI advancements in healthcare.

AIMPACT message, May 1 (UTC+8): On April 30, 2026, DeepMind announced the launch of the AI Co-Clinician research initiative, exploring how multimodal AI agents can assist medical decision-making under physician supervision. The system enables real-time interaction via video and audio to collect patient histories, guide physical examinations, perform preliminary diagnostic reasoning (e.g., rotator cuff injury or tendonitis), provide care recommendations, and clearly disclose that it is not a physician—所有建议需在医生监督下使用. Technical features: Real-time multimodal processing (analyzing gait, respiration, rashes, etc.), dual-agent architecture (Planner continuously monitors Talker to enforce safety boundaries), and the NOHARM safety framework. Test results: Among 98 primary care queries, 97 achieved zero critical errors; in 20 simulated scenarios across 140 evaluation dimensions, 68 dimensions matched or exceeded physician performance (particularly in triage), while human physicians retained clear advantages in identifying critical “red flag” signs and guiding examinations. The project is collaborating with Harvard Medical School, Stanford School of Medicine, and others, and is currently in the research phase, with plans to gradually expand clinical testing. DeepMind emphasizes that the AI is designed to act as a “collaborative member” to augment, not replace, clinical judgment. (Source: BlockBeats)

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.